With the analysis among 537,905 patents, we discovered top 484 key players by total patent application. Novartis AG, AstraZeneca Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 4.53% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 11,843
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 6,563
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 4,683
New York, United States
Patent: 4,646
Indiana, United States
Patent: 4,230
Antwerpen, Belgium
Patent: 4,168
New York, United States
Patent: 3,315
Connecticut, United States
Patent: 2,643
Hounslow, United Kingdom
Patent: 2,595
With the analysis among 12,960 patents, we discovered top 406 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Cellix Bio Pvt Ltd., Alkahest, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Telangana, India
Patent: 297
California, United States
Patent: 173
Prilenia Therapeutics Development Ltd.
DUBLIN, Ireland
Patent: 145
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 126
Intarcia Therapeutics, Inc.
California, United States
Patent: 118
United Kingdom
Patent: 116
California, United States
Patent: 115
California, United States
Patent: 103
With the analysis among related 237,593 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, F. Hoffmann-La Roche Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 2.13% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 2,431
F. Hoffmann-La Roche Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1,284
Indiana, United States
Patent: 1,122
Antwerpen, Belgium
Patent: 1,036
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1,012
Regents of the University of California
California, United States
Patent: 1,002
New York, United States
Patent: 991
Nordrhein-Westfalen, Germany
Patent: 923
New York, United States
Patent: 877
With the analysis among related 237,593 patents in last 5 years, we discover 14 new entrants. Suzhou Yasheng Pharmaceutical Co., Ltd., Inflazome Ltd., Aligos Therapeutics, Inc. are the most active new entrants in this area.
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 161
DUBLIN, Ireland
Patent: 145
Aligos Therapeutics, Inc.
California, United States
Patent: 128
Ascentage Pharma Group Corp. Ltd.
Shanghai Shi, China
Patent: 119
New York, United States
Patent: 105
California, United States
Patent: 103
Wigen Biomedicine technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 99
Foghorn Therapeutics, Inc.
Massachusetts, United States
Patent: 90
Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd.
Shanghai Shi, China
Patent: 83
Shanghai Jiyu Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 82
With the analysis among 85,089 patents, we discovered top 326 universities and scientific research institutions by total patent application. China Pharmaceutical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, The Johns Hopkins University are dominant in this area. They take 5.90% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1,137
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 964
The Johns Hopkins University
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 652
Chinese Academy of Medical Scciences & Peking Union Medical College
Shanghai Shi, China
Patent: 591
Zhejiang Sheng, China
Patent: 524
Connecticut, United States
Patent: 499
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 496
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 473